相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Positive Diagnostic Strategy Is Noninferior to a Strategy of Exclusion for Patients With Irritable Bowel Syndrome
Luise M. Begtrup et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome
Chad K. Porter et al.
BMC GASTROENTEROLOGY (2012)
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Rebecca M. Lovell et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Resource Use and Costs Associated with Coeliac Disease before and after Diagnosis in 3,646 Cases: Results of a UK Primary Care Database Analysis
Mara Violato et al.
PLOS ONE (2012)
The Yield of Colonoscopy in Patients With Non-Constipated Irritable Bowel Syndrome: Results From a Prospective, Controlled US Trial
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Is Irritable Bowel Syndrome a Diagnosis of Exclusion?: A Survey of Primary Care Providers, Gastroenterologists, and IBS Experts
Brennan M. R. Spiegel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study
R. Corinaldesi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Yield of Diagnostic Tests for Celiac Disease in Individuals With Symptoms Suggestive of Irritable Bowel Syndrome Systematic Review and Meta-analysis
Alexander C. Ford et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
The relationship between time since registration and measured incidence rates in the General Practice Research Database
JD Lewis et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)
Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis
SM Mein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Fracture risk in people with celiac disease: A population-based cohort study
J West et al.
GASTROENTEROLOGY (2003)
Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome?
A Ruigómez et al.
MATURITAS (2003)
Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease
JD Lewis et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Risk of irritable bowel syndrome among asthma patients
C Huerta et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral
WG Thompson et al.
GUT (2000)
分享论文
